Skip navigationThe Human Genome site
The Wellcome Trust
Wellcome Trust websites | Sitemap | Contact us
In the genome Genes and the body Tackling disease Genetics and society In depth Resources What's new
 
Home > In depth > Cancer file

Cancer file

Cancer is the most common human genetic disease. Approximately one in three people in Europe and North America develops one of the approximately 200 different types of cancer, and it is the cause of death of one in five.
News
Image for New cancer gene identified by Trust-funded research
Mutations in the UTX gene have been found in many different types of cancer - including kidney cancer, multiple melanoma and oesophogeal cancer - according to a study funded by the Wellcome Trust. The finding, from researchers on the Cancer Genome Project, offers a new avenue for research that could lead to new cancer treatments. 30/03/09
News
Image for Cancer genes: Drivers unwanted
The Cancer Genome Project has found mutations in 120 kinase genes that appear to 'drive' cancer. 14/03/07
News
Researchers from four continents announced the launch of the International Cancer Genome Consortium (ICGC), a major collaboration designed to identify the key genetic mutations involved in up to 50 types of cancer. 29/04/08
News
Women who inherit one damaged copy of the PALB2 gene have double the risk of developing breast cancer, and children who inherit two damaged copies have a newly identified serious disorder linked to childhood tumours. 19/02/07
News
A woman is pregnant with what is thought to be the first child in the UK to have been selected to be free of a cancer gene, The Times has reported. 15/05/06
News
A new international phase II clinical trial is to look at the effect of a novel form of drug treatment for metastatic hereditary breast cancer. 02/05/06
News
Lung tumours are found to become resistant to two drugs when they acquire a new genetic mutation. 07/03/05
News
The Human Fertilisation and Embryology Authority (HFEA) has approved the screening of embryos, using pre-implantation genetic diagnosis, for familial adenomatous polyposis, an inherited bowel cancer. 02/11/04
News
Inheriting the wrong version of a gene called CHEK2 doubles a woman's risk of developing breast cancer, Cancer Research UK scientists have confirmed. 17/05/04
Features
Small-molecule drug used to treat chronic myeloid leukaemia. 19/04/04
Features
An RNA molecule that can inhibit the growth of new blood vessels around tumours. 19/04/04
News
The report 'Securing Good Health for the Whole Population', by Government adviser Derek Wanless has been published. 26/02/04
Features
A therapeutic antibody used to treat advanced breast cancer. 04/02/04
Features
DNA arrays can be used to classify different types of cancer that may be difficult to distinguish by other methods. 27/08/03
News
Predicting therapeutic response in breast cancer patients. 13/08/03
News
A common variant of the Aurora2 gene may increase susceptibility to cancer development – one of the first examples of a 'low penetrance' tumour susceptibility gene in humans. 24/07/03
News
DNA microarrays ('chips') have been used to identify a gene expression 'signature' that can distinguish non-metastatic primary tumours both from metastatic tumours and from primary tumours that are destined to metastasise. 21/03/03
Features
Large-scale protein analysis can identify cancer-related proteins that can be used as diagnostic markers and perhaps as targets for drug development. 02/02/03
News
A new Government advisory committee report looks at the interaction between genes, environmental chemicals and cancer. 11/07/02
News
The Cancer Genome Project has identified a major genetic change involved in 70 per cent of cases of malignant melanoma. 09/06/02
News
Two studies find that removal of the ovaries reduces cancer risk in BRCA mutation carriers. 31/05/02
Background
Mutations in several different types of genes are involved in cancer. Some of these genes control growth, or stop excessive growth, while others control a cell's blood supply or its position in the body. 08/06/00
Background
The transition from a normal cell to a malignant cancer is driven by changes to the cell's DNA. 08/06/00
Gibbs Building, 215 Euston Road, London NW1 2BE, UK   tel:+44 (0)20 7611 8888   email:genome@wellcome.ac.uk Privacy statement|Disclaimer|About this site